前列腺光选择性汽化术与电切术后再治疗及医疗资源利用的基于人群评估
PVP组再手术风险显著更高(aHR 1.57),30天急诊返回风险略高(aOR 1.11),但输血风险显著更低(aOR 0.24),且多数PVP患者住院不足24小时。
要点
- PVP组再手术风险显著高于电切组(aHR 1.57,95%CI 1.38-1.78)。
- PVP组输血风险显著低于电切组(aOR 0.24,95%CI 0.16-0.37)。
- PVP组73%住院不足24小时,电切组仅7%。
核心结论
- PVP虽降低输血风险和缩短住院,但再手术率显著高于电切术。
主要发现
- PVP组再手术风险显著更高(aHR 1.57,95%CI 1.38-1.78;绝对风险差+2.3%)。
- PVP组30天内返回急诊风险略高(aOR 1.11,95%CI 1.01-1.22)。
- PVP组输血风险显著更低(aOR 0.24,95%CI 0.16-0.37)。
- PVP组73%住院不足24小时,电切组为7%。
临床怎么用
- 临床选择PVP时应权衡其降低输血和缩短住院的优势与再手术风险增加的可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the healthcare utilisation and repeat surgical treatment rate amongst older men undergoing an electrosurgical-transurethral resection of the prostate (TURP) vs photoselective vaporisation of the prostate (PVP), as the real-world implementation and outcomes of laser-based treatment have not been well studied. PATIENTS AND METHODS: We used administrative data from the province of Ontario, Canada, to identify all men aged >66 years who underwent their first electrosurgical-TURP/PVP between 2003 and 2016. Our primary exposure was type of procedure (PVP or electrosurgical-TURP). Our primary outcome was need for repeat surgical treatment. The primary analysis was an adjusted marginal Cox model approach, which accounted for clustering of patients within surgeons; adjusted hazard ratios (aHRs) or odds ratios (aORs) and 95% confidence intervals (CIs) are reported. RESULTS: We identified 52 748 men: 6838 (13%) underwent PVP, and 45 910 (87%) underwent electrosurgical-TURP. The median age was similar, and PVP became more common with time. Compared to the PVP group, more patients in the electrosurgical-TURP group had prior gross haematuria or urinary retention, and fewer had used anticoagulants, α-blockers, or 5α-reductase inhibitors. The need for repeat surgical treatment was significantly higher amongst men who had PVP (aHR 1.57, 95% CI 1.38-1.78; absolute risk difference +2.3%). PVP was also associated with a slightly higher risk of return to the emergency room within 30 days (aOR 1.11, 95% CI 1.01-1.22) and a significantly lower risk of blood transfusion (aOR 0.24, CI 0.16-0.37); the majority of PVP cases were done with a <24 h stay (73%) vs electrosurgical-TURP (7%). CONCLUSIONS: While some of the expected benefits of PVP (such as reduced transfusion risk and shorter length of stay) were observed, the significantly higher rate of repeat surgical treatment compared to electrosurgical-TURP may represent an important difference in implementation of this technology outside of clinical trials.
引用
- Welk B, Reid J, Ordon M, et al. Population-based assessment of re-treatment and healthcare utilisation after photoselective vaporisation of the prostate or electrosurgical transurethral resection of the prostate. BJU Int. 2019. PMID: 31389161. doi:10.1111/bju.14891
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。